Opaleye Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Hold |
105,000
| – | – | 1.17% | 21 |
|
|
2025
Q1 | $5.08M | Hold |
105,000
| – | – | 1.13% | 16 |
|
|
2024
Q4 | $4.05M | Hold |
105,000
| – | – | 0.71% | 27 |
|
|
2024
Q3 | $4.73M | Hold |
105,000
| – | – | 0.79% | 25 |
|
|
2024
Q2 | $3.64M | Sell |
105,000
-7,700
| -7% | -$267K | 0.83% | 33 |
|
|
2024
Q1 | $3.26M | Hold |
112,700
| – | – | 0.71% | 34 |
|
|
2023
Q4 | $2.58M | Buy |
+112,700
| New | +$2.58M | 0.69% | 36 |
|
|
2022
Q2 | – | Sell |
-251,500
| Closed | -$5.96M | – | 51 |
|
|
2022
Q1 | $5.96M | Sell |
251,500
-90,500
| -26% | -$2.14M | 1.85% | 18 |
|
|
2021
Q4 | $11.7M | Buy |
342,000
+11,778
| +4% | +$403K | 2.48% | 13 |
|
|
2021
Q3 | $5.85M | Hold |
330,222
| – | – | 1.09% | 28 |
|
|
2021
Q2 | $14.8M | Buy |
330,222
+33,222
| +11% | +$1.49M | 2.46% | 13 |
|
|
2021
Q1 | $7.69M | Buy |
297,000
+37,000
| +14% | +$958K | 1.13% | 28 |
|
|
2020
Q4 | $7.02M | Buy |
+260,000
| New | +$7.02M | 0.92% | 28 |
|